MRX, Radiation, and Chemotherapy for Patients With Resected Squamous Cell Carcinoma of the Head and Neck

NCT00427102 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

OTHER

Sponsor class

Stopped No subjects enrolled and PI went to another facility

Conditions

Squamous Cell Carcinoma
Head and Neck Cancer
Resected Head and Neck Cancer
Mucositis

Interventions

DRUG: Oral MRX-1024
PROCEDURE: Standard Fractionation Radiation Therapy
DRUG: High-Dose Cisplatin Chemotherapy

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins